On March 12, 2014, two events of yellow fever were reported in the North and in the South of the Democratic Republic of Congo (DRC). Six laboratory-confirmed cases with yellow fever virus infection were reported. Of these, three were from Bondo health zone1, Orientale Province, two from Buta health zone, Orientale Province and one from Kikondja health zone, Katanga Province. In total 139 suspected, probable and confirmed cases, including six deaths were reported.
In Bondo district, the index case was a 40-year-old man who became ill with fever and jaundice on Dec. 10, 2013. His yellow fever vaccination status is not known. Laboratory confirmation was conducted by the Institute National of Biomedical Research (INRB) in Kinshasa, which showed IgM positive by ELISA test. Reconfirmation of the laboratory test was conducted by the regional reference laboratory for yellow fever at the Institut Pasteur in Dakar, Senegal with a more specific test for yellow fever (plaque reduction neutralization test or PRNT), with exclusion of exclusion of other arbovirus.
The second case was reported in the same health zone on Jan. 30, 2014 and laboratory-confirmation was conducted on March 11, 2014. The patient’s vaccination status for yellow fever is not known.
Preliminary outbreak investigations revealed that in Bondo and the health district of Buta, at least 116 suspected cases were reported.
In Kikondja district, the index case was a 19-year-old woman reported by the Health Center of Ntwadi on Feb. 17, 2014. The case was laboratory-confirmed by INRB and IP Dakar. Following identification of the index case, an outbreak investigation was conducted in three villages, Katongue, Kimbuvu and Lukila, where 23 suspected cases were identified.
International Coordinating Group on Yellow Fever Vaccine Provision (YF-ICG2), approved the provision of 559,876 doses of yellow fever vaccine and operational costs for a reactive mass vaccination campaign.
A reactive mass vaccination campaign is being planned for May 1, 2014. The campaign will be headed by the Ministry of Health, DRC, with support from the GAVI Alliance, Médecin sans frontières (MSF) and other partners. WHO is closely supporting the management of the outbreak in monitoring, preventive and control activities in the field, and in resource mobilization.
Source: World Health Organization (WHO)
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.